Cardiac involvement in a patient with B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia and a history of allogeneic hematopoietic stem cell transplantation and CAR T-cell therapy: A case report

被引:1
|
作者
Cao, Yigeng [1 ,2 ]
Liu, Yadan [3 ]
Zhang, Rongli [1 ,2 ]
Zhai, Weihua [1 ,2 ]
Ma, Qiaoling [1 ,2 ]
Wei, Jialin [1 ,2 ]
Yang, Donglin [1 ,2 ]
Pang, Aiming [1 ,2 ]
He, Yi [1 ,2 ]
Chen, Xin [1 ,2 ]
Jiang, Erlie [1 ,2 ]
Feng, Sizhou [1 ,2 ]
Han, Mingzhe [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
[3] Ningbo First Hosp, Ningbo Clin Res Ctr Hematol Malignancies, Hematol Dept, Ningbo, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 13卷
关键词
B cell acute lymphoblastic leukemia; B cell lymphoblastic lymphoma; allogeneic hematopoietic stem cell transplantation; chimeric antigen receptor T cells; cardiac involvement; MANAGEMENT; DIAGNOSIS; NEOPLASMS;
D O I
10.3389/fimmu.2022.1052336
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiac involvement in hematological malignancies is uncommon, with only a few cases reported to date, and it often leads to a poor prognosis. Here, we report a case of a 42-year-old woman with a history of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia in whom cardiac mass and myocardial infiltration were detected. Prior to this presentation, massive pericardial effusion had occurred 6 months after CAR T-cell therapy, which was improved via ultrasound-guided pericardiocentesis. We observed elevated cytokine levels and increased copy number of CAR DNA in both pericardial effusion and serum. Upon detecting cardiac mass and myocardial infiltration, the patient was administered tocilizumab (a humanized monoclonal antibody against IL-6 receptor), which controlled the serum cytokine levels, and reduced intensity chemotherapy, including vindesine, cyclophosphamide, and prednisolone. However, the patient finally died of multiple organ failure. To the best of our knowledge, this is the first report on the development of a cardiac mass and occurrence of myocardial infiltration after allo-HSCT and CAR T-cell therapy. This report may provide supporting data for the early diagnosis and immediate treatment of patients with cardiac involvement.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
    Chen, Runzhe
    Campbell, Jos L.
    Chen, Baoan
    ONCOTARGETS AND THERAPY, 2015, 8 : 405 - 412
  • [32] Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma
    Cahill, Kirk E.
    Leukam, Michael J.
    Riedell, Peter A.
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 799 - 807
  • [33] Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments
    Xu, Xinjie
    Huang, Shengkang
    Xiao, Xinyi
    Sun, Qihang
    Liang, Xiaoqian
    Chen, Sifei
    Zhao, Zijing
    Huo, Zhaochang
    Tu, Sanfang
    Li, Yuhua
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [34] CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymphoblastic leukemia
    Liu, Jie
    Xu, Mengyuan
    Zhang, Xiaoqian
    Zhang, Zhuo
    Zhong, Tao
    Yu, Hongjuan
    Fu, Yueyue
    Meng, Hongbin
    Feng, Jiawei
    Zou, Xindi
    Han, Xueying
    Kang, Liqing
    Yu, Lei
    Li, Limin
    HELIYON, 2024, 10 (13)
  • [35] T-Cell Lymphoblastic Lymphoma with Cutaneous Involvement in a Child: A Rare Case Report
    Chen, Jiaoquan
    Tian, Xin
    Yu, Nanji
    Peng, Liqian
    Zhu, Huilan
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2027 - 2033
  • [36] Disseminated Fusariosis Caused by Fusarium verticillioides in an Acute Lymphoblastic Leukemia Patient after Allogeneic Hematopoietic Stem Cell Transplantation
    Tezcan, Gulsum
    Ozhak-Baysan, Betil
    Alastruey-Izquierdo, Ana
    Ogunc, Dilara
    Ongut, Gozde
    Yildiran, Sinasi Taner
    Hazar, Volkan
    Cuenca-Estrella, Manuel
    Luis Rodriguez-Tudela, Juan
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (01) : 278 - 281
  • [37] Intrahepatic cholangiocarcinoma as a rare secondary malignancy after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia: A case report
    Good, Meghan L.
    Malekzadeh, Parisa
    Kriley, Isaac R.
    Shah, Nirali N.
    Kleiner, David E.
    Calvo, Katherine
    Hernandez, Jonathan M.
    Davis, Jeremy L.
    PEDIATRIC TRANSPLANTATION, 2020, 24 (02)
  • [38] Long-Term Survival and Immune Reconstitution of Donor-Derived Chimeric Antigen Receptor T-Cell Therapy for Childhood Molecular Relapse of B-Cell Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Hu, Guan-hua
    Zuo, Ying-xi
    Suo, Pan
    Bai, Lu
    Zhang, Xiao-hui
    Wang, Yu
    Cheng, Yi-fei
    Huang, Xiao-jun
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (08) : 583 - 595
  • [39] Hematopoietic stem cell transplantation in children and adolescents with nonremission acute lymphoblastic leukemia
    Okamoto, Yasuhiro
    Nakazawa, Yozo
    Inoue, Masami
    Watanabe, Kenichiro
    Goto, Hiroaki
    Yoshida, Nao
    Noguchi, Maiko
    Kikuta, Atsushi
    Kato, Koji
    Hashii, Yoshiko
    Atsuta, Yoshiko
    Kato, Motohiro
    PEDIATRIC BLOOD & CANCER, 2020, 67 (12)
  • [40] Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia
    Wang, Xiangmin
    Zhang, Bingpei
    Zhang, Qing
    Zhou, Hongyuan
    Sun, Qian
    Zhou, Yi
    Li, Tianci
    Zhou, Dian
    Shen, Ziyuan
    Zhang, Jiaoli
    Li, Ping
    Liang, Aibin
    Zhou, Keshu
    Han, Lu
    Hu, Yongxian
    Yang, Yun
    Cao, Jiang
    Li, Zhenyu
    Xu, Kailin
    Sang, Wei
    CANCER, 2024, 130 (15) : 2660 - 2669